Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site, 2: relevance of an N-terminal helix. 2003

Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
Dipartimento di Chimica, Università di Napoli Federico II, Complesso Universitario Monte S. Angelo, Via Cintia, 80126 Napoli, Italy.

Proteolytic activation of the HIV-1 envelope glycoprotein gp160 is selectively performed by the proprotein convertase furin at the C-terminus of the sequence R508-E-K-R511 (site 1), in spite of the presence of another consensus sequence, Lys500-Ala-Lys-Arg503 (site 2). On the basis of the solution structural analysis of the synthetic peptide p498, spanning the gp160 sequence Pro498-Gly516, we previously suggested a possible role of an N-terminal helix in regulating the exposure and accessibility of the gp160 physiological cleavage site, enclosed in a loop. Here we report on the activity and conformation of the 23-residue peptide h-REKR, designed to exhibit a large N-terminal helix, followed by the gp160 native sequence, Arg508-Gly516. h-REKR is digested by furin with high efficiency, comparable to the full native p498. Circular dichroism analyses, in mixtures from pure water to 98 % trifluoroethanol, outline a significant content of helical structure in the peptide conformation. The molecular model obtained from NMR data collected in trifluoroethanol/water, by means of DYANA and AMBER simulations, indeed has helical structure on a large N-terminal segment. Such a long helix does not seem to affect the loop conformation of the C-terminal site 1-containing sequence, which exhibits the same proton chemical shifts already observed for the full native p498.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013381 Subtilisins A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.- Alcalase,AprA-Subtilisin,Bacillus amyloliquefaciens Serine Protease,Bacillus subtilis Alkaline Proteinase,Carlsberg Subtilisin,Maxatase,Nagarse,Novo Alcalase,Profezim,Protease VII,Subtilisin 72,Subtilisin A,Subtilisin BPN',Subtilisin Carlsberg,Subtilisin DY,Subtilisin E,Subtilisin GX,Subtilisin Novo,Subtilopeptidase A,Alcalase, Novo,AprA Subtilisin,Subtilisin, Carlsberg
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
July 1998, Biochemistry,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
March 1998, Biochemistry,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
December 1988, Proceedings of the National Academy of Sciences of the United States of America,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
January 1999, FEBS letters,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
November 1992, Nature,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
January 1991, Journal of acquired immune deficiency syndromes,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
January 1990, Virology,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
November 1989, Journal of virology,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
July 2009, Journal of bioscience and bioengineering,
Romina Oliva, and Lucia Falcigno, and Gabriella D'Auria, and Monica Dettin, and Claudia Scarinci, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
March 2017, Nature communications,
Copied contents to your clipboard!